LINC00665 can enhance the resistance of tumor cells to various chemotherapeutic drugs, including the resistance of non-small cell lung cancer cells to gefitinib and cisplatin [6,7], and the resistance of cholangiocarcinoma cells to gemcitabine [8]. The gene discussed is LINC00665; the disease is non-small cell lung carcinoma.